Cronos (CRON) Shares Outstanding (2016 - 2026)
Cronos (CRON) posted quarterly Shares Outstanding (Entity) of $376.3 million for Q1 2026, down 2.37% year-over-year from $385.4 million in Q1 2025, and down 1.4% quarter-over-quarter from $381.6 million in Q4 2025.
Cronos (CRON) Shares Outstanding (2016 - 2026) Analysis & Trends
Cronos' Shares Outstanding (Entity) history runs 11 years deep, the most recent figure standing at $376.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 2.37% year-over-year to $376.3 million; the TTM figure through Mar 2026 stood at $376.3 million (down 2.37% YoY), while the FY2025 annual figure was $381.6 million, changed 0.25% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $376.3 million, down from $381.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $385.4 million in Q1 2025, with the low at $375.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $381.3 million (2023), against an average of $380.9 million.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) gained 1.64% in 2022, then dropped 2.37% in 2026.
- Cronos' Shares Outstanding (Entity) stood at $380.6 million in 2022, then advanced by 0.19% to $381.3 million in 2023, then increased by 0.32% to $382.5 million in 2024, then retreated by 0.25% to $381.6 million in 2025, then retreated by 1.4% to $376.3 million in 2026.
- Business Quant data shows CRON's Shares Outstanding (Entity) at $376.3 million in Q1 2026, $381.6 million in Q4 2025, and $382.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 373.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 373.61 Mn |
| Mar 31, 2026 | 379.37 Mn |
| Dec 31, 2025 | 383.47 Mn |
| Sep 30, 2025 | 383.09 Mn |
| Jun 30, 2025 | 385.31 Mn |
| Mar 31, 2025 | 382.96 Mn |
| Dec 31, 2024 | 382.06 Mn |
| Sep 30, 2024 | 382.29 Mn |
| Jun 30, 2024 | 382.16 Mn |
| Mar 31, 2024 | 381.44 Mn |
| Dec 31, 2023 | 380.96 Mn |
| Sep 30, 2023 | 381.10 Mn |
| Jun 30, 2023 | 380.96 Mn |
| Mar 31, 2023 | 380.63 Mn |
| Dec 31, 2022 | 376.96 Mn |
| Sep 30, 2022 | 378.11 Mn |
| Jun 30, 2022 | 376.03 Mn |
| Mar 31, 2022 | 375.02 Mn |
| Dec 31, 2021 | 370.39 Mn |
| Sep 30, 2021 | 372.46 Mn |